UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Apple
AAPL
|
+$615M |
| 3 |
NVIDIA
NVDA
|
+$609M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$1.07B |
| 2 |
Tesla
TSLA
|
+$467M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$262M |
| 4 |
Match Group
MTCH
|
+$241M |
| 5 |
Valero Energy
VLO
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.89% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 6.45% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Communication Services | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Warby Parker
WRBY
$3.27B
| $3.33M | ﹤0.01% |
203,747
+39,508
| +24% | +$595K |
|
|
NARI
3477
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.32M | ﹤0.01% |
80,469
+58,044
| +259% | +$2.79M |
|
3478
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$784M
| $3.31M | ﹤0.01% |
102,736
+11
| +0% | +$344 |
|
|
VRE
3479
DELISTED
Veris Residential
VRE
| $3.31M | ﹤0.01% |
185,396
+63,034
| +52% | +$1.04M |
|
3480
iShares Morningstar Small-Cap Growth ETF
ISCG
$1.02B
| $3.31M | ﹤0.01% |
67,579
-12,138
| -15% | -$571K |
|
|
TRTX
3481
TPG RE Finance Trust
TRTX
$618M
| $3.31M | ﹤0.01% |
387,838
+99,160
| +34% | +$870K |
|
3482
Bankunited
BKU
$3.36B
| $3.3M | ﹤0.01% |
90,635
-10,446
| -10% | -$371K |
|
3483
Lloyds Banking Group
LYG
$91.3B
| $3.3M | ﹤0.01% |
1,057,947
+352
| +0% | +$1.06K |
|
|
EFOR
3484
Everforth Inc
EFOR
$1.32B
| $3.3M | ﹤0.01% |
35,394
-34,376
| -49% | -$3.19M |
|
3485
Vanguard US Minimum Volatility ETF
VFMV
$446M
| $3.3M | ﹤0.01% |
27,125
-115
| -0.4% | -$13.6K |
|
3486
WisdomTree Europe SmallCap Dividend Fund
DFE
$169M
| $3.3M | ﹤0.01% |
51,931
+625
| +1% | +$38.8K |
|
3487
Mayville Engineering Co
MEC
$617M
| $3.29M | ﹤0.01% |
156,265
-64,209
| -29% | -$1.2M |
|
3488
Oaktree Specialty Lending
OCSL
$1.14B
| $3.29M | ﹤0.01% |
201,635
-85,971
| -30% | -$1.47M |
|
3489
Herc Holdings
HRI
$5.61B
| $3.28M | ﹤0.01% |
20,599
+2,865
| +16% | +$406K |
|
|
RVNC
3490
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.28M | ﹤0.01% |
632,553
+581,780
| +1,146% | +$2.89M |
|
|
ALTR
3491
DELISTED
Altair Engineering Inc
ALTR
| $3.28M | ﹤0.01% |
34,366
+11,240
| +49% | +$1.02M |
|
|
RMM
3492
RiverNorth Managed Duration Municipal Income Fund
RMM
$290M
| $3.28M | ﹤0.01% |
204,204
-2,774
| -1% | -$43.1K |
|
3493
VSE Corp
VSEC
$6.12B
| $3.28M | ﹤0.01% |
39,662
+2,928
| +8% | +$255K |
|
3494
CALL
PACCAR
PCAR
$70.1B
| $3.28M | ﹤0.01% |
33,200
| – | – |
|
|
HTT
3495
High Templar Tech Ltd
HTT
$391M
| $3.27M | ﹤0.01% |
1,535,292
-400,193
| -21% | -$740K |
|
3496
PUT
Scotiabank
BNS
$108B
| $3.27M | ﹤0.01% |
60,000
| – | – |
|
3497
CG Oncology
CGON
$6.66B
| $3.26M | ﹤0.01% |
86,534
+8,454
| +11% | +$296K |
|
|
UCB
3498
United Community Banks
UCB
$4.28B
| $3.26M | ﹤0.01% |
112,167
+22,081
| +25% | +$634K |
|
|
CXE
3499
DELISTED
MFS High Income Municipal Trust
CXE
| $3.26M | ﹤0.01% |
814,244
+2,413
| +0.3% | +$9.24K |
|
3500
PagerDuty
PD
$902M
| $3.26M | ﹤0.01% |
175,756
-171,339
| -49% | -$3.34M |
|
Similar funds
UBS Group's Q3 2024 Portfolio in Review
As of Q3 2024, UBS Group held 10,551 positions worth $459B, up 13% from $405B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS Group deployed $30.4B of net new capital in Q3 2024, opening 1,098 new positions and adding to 4,837 existing holdings. Its largest new stake was Smurfit Westrock: 973,061 shares worth $48.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Nike, an estimated $1.07B trimmed.
- UBS Group's largest Q3 2024 buy was Smurfit Westrock: 973,061 shares worth $48.1M.
- UBS Group added most to Meta Platforms (Facebook) in Q3 2024, an estimated $694M increase.
- UBS Group's biggest Q3 2024 reduction was Nike, cutting an estimated $1.07B.
- UBS Group fully exited WestRock Company in Q3 2024, selling an estimated $161M.
- UBS Group's ten largest holdings make up 17% of its $459B portfolio in Q3 2024.
- UBS Group opened 1,098 new positions and closed 1,108 in Q3 2024.
- UBS Group's portfolio value rose 13% quarter-over-quarter to $459B.
Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.